Coronavirus live news: UK starts vaccinating 12- to 15-year-olds; China reports 49 new cases

Children will be offered jabs at school from Monday; China cases down from 66 a day earlier

China reported on Monday 49 new confirmed coronavirus cases in the mainland for Sept. 19, down from 66 a day earlier, according to National Health Commission data.

Of the new infections, 28 were locally transmitted, all of them in the southeastern province of Fujian, the health authority said. That compares with 43 local cases a day earlier.

China reported two new asymptomatic coronavirus cases, which it does not classify as confirmed infections, compared with 19 a day earlier.

No new deaths were reported.

As of Sunday, mainland China had recorded 95,738 confirmed cases, with the death toll unchanged at 4,636.

Coronavirus vaccines are being rolled out to children aged between 12 and 15, with three million youngsters eligible across the UK, PA media reports.

The programme is expected to be delivered primarily within schools, and guidance has been issued to headteachers to contact police if they believe protests could be held outside their buildings.

Children will be offered jabs at some schools in England from Monday.

The rollout for 12 to 15-year-olds is also beginning in Scotland and Wales this week.
Young people in this age bracket in Scotland can go to drop-in clinics or wait for a letter offering them a scheduled appointment.

Jabs for children in Wales will be carried out at mass vaccination centres and some school settings.

In Northern Ireland, the head of the region’s vaccination programme said jabs are likely to be offered to children aged 12 to 15 in schools from October.

Continue reading...

Coronavirus | The Guardian

Comments

Post a Comment

Popular posts from this blog

The world’s economic recovery from Covid-19 looks likely to be uneven | Nouriel Roubini

The bounce-back will be stronger in the US and China, but Europe and Japan face a slower restart Coronavirus – latest updates See all our coronavirus coverage After the most severe global recession in decades, private and official forecasters are increasingly optimistic that world output will recover strongly this year and thereafter. But the coming expansion will be unevenly distributed, both across and within economies. Whether the recovery is V-shaped (a strong return to above-potential growth), U-shaped (a more anemic version of the V) or W-shaped (a double-dip recession) will depend on several factors across different economies and regions. With the coronavirus still running rampant in many countries, one key question is whether the emergence of virulent new strains will trigger repeated stop-and-go cycles, as we’ve seen in some cases where economies reopened too soon. One particularly ominous possibility is that more vaccine-resistant variants appear, heightening the urgenc...
Read more

As Covid mutates, the vaccine makers are adapting too

Focus on the exciting potential of T-cell immunity is spurring the sector on to create a new generation of jabs The speed at which scientists worked to develop the first Covid jabs was unprecedented. Just nine months after the UK went into lockdown, 90-year-old Margaret Keenan officially became the first person in the world outside a trial to receive the Pfizer/BioNTech vaccine. But the virus is mutating, and the emergence of the Omicron variant last month is already focusing attention on the next generation of jabs. So what do we know about the new Covid-19 vaccines? One change is with delivery mechanisms, such as San Francisco firm Vaxart’s vaccine-in-a-pill, and Scancell’s spring-powered injectors that pierce the skin without a needle. But the biggest development is in T-cell technology. Produced by the bone marrow, T-cells are white blood cells that form a key part of the immune system. While current vaccines mainly generate antibodies that stick to the virus and stop it infect...
Read more